ArticleFrontiers in medicine2026
Postoperative vascular compromise after digital replantation or revascularization: timing, risk factors, and salvage outcomes in a single-center retrospective cohort.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative vascular compromise remains a clinically important threat after digital replantation or revascularization, but its timing, clinical presentation, risk factors, and post-compromise salvage profile are often less systematically reported than final survival. Methods: We performed a single-center retrospective cohort study using digit-level records. The primary outcome was postoperative vascular compromise at the digit level. Compromise type, the operation-start-referenced interval to first documentation of compromise, recorded management components, and salvage success, defined as complete survival or partial survival with digit preservation and without secondary amputation, were summarized. Logistic regression with patient-cluster robust standard errors was used for the vascular-compromise model; salvage models were exploratory complete-case analyses. Results: This single-center retrospective study enrolled 671 digits from 484 patients. Postoperative vascular compromise occurred in 128 of 671 digits (19.1%). Venous congestion was the most common presentation (71.9%), followed by arterial insufficiency (21.1%) and mixed compromise (7.0%). The median operation-start-referenced interval to first documentation of vascular compromise was 15.88 h (IQR, 8.03-34.52), and 112 of 128 events (87.5%) were first documented within 48 h after the recorded operation-start timestamp. In the parsimonious multivariable vascular-compromise model, complete amputation (OR, 2.853; 95% CI, 1.780-4.575), vein grafting (OR, 2.963; 95% CI, 1.615-5.437), and longer operative duration (OR per hour, 1.079; 95% CI, 1.010-1.152) were associated with higher odds of compromise, whereas a greater number of arterial anastomoses was associated with lower odds (OR, 0.526; 95% CI, 0.331-0.835). Among compromise digits, salvage success was achieved in 81 of 128 digits (63.3%). Any recorded thrombolysis was associated with lower odds of salvage success in an exploratory complete-case model ( Conclusions: In this single-center retrospective cohort, approximately one in five replanted or revascularized digits developed postoperative vascular compromise, most commonly venous congestion. Complete amputation, vein grafting, longer operative duration, and fewer arterial anastomoses were associated with compromise and may help identify digits requiring intensified early surveillance. Post-compromise treatment-outcome findings should be interpreted as exploratory associations rather than causal effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.